Back to Main

Faculty Detail    
Name DEJUN SHEN
 
Campus Address NP 3546 Zip 7331
Phone 205-975-8317
E-mail shend@uab.edu
Other websites https://sites.google.com/site/bidmcbreastpathology/
     


Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Pathology   Anatomic Pathology Assistant Professor
Center  Center for Aging  COMPREHENSIVE CTR FOR HEALTHY AGING Assistant Professor
Center  Comprehensive Cancer Center  Comprehensive Cancer Center Assistant Professor

Biographical Sketch 
Education
1. M.D., 09/1981- 07/1986, Zhejiang Medical University, Hangzhou, China
2. Ph.D., 09/1989-12/1994, Zhejiang Medical University, Hangzhou, China
3. Pathology residency, Anatomic and Clinical Pathology, 07/2006-06/2010, University of Southern California, Keck School of medicine, Los Angeles, CA
4. Breast pathology fellowship, 07/2010-06/2011, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
5. Surgical pathology fellowship, 07/2011-12/2011, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Society Memberships
Organization Name Position Held Org Link
American Society for Clinical Pathology (ASCP)  Fellow  http://www.ascp.org/ 
Collage of American Pathologists (CAP)  Fellow  http://www.cap.org/apps/cap.portal 
United States & Canadian Academy of Pathology (USCAP)  Member  http://www.uscap.org/home.htm 

Research/Clinical Interest
Title
Cancer biomarker identification
Description
For clinical aspect, I am interested in improving cancer pathology diagnosis of breast, genitourinary tract and gastrointestinal tract. For research aspect, I am interested in cancer biomarker research with two projects ongoing: (1) bioinformatics data mining of cancer genomic data; (2) molecular imaging of breast lumpectomy. For the 1st project, we are performing data mining of The Cancer Genome Atlas (TCGA) sequencing data in an attempt to characterize the genomic features correlated with cancer histopathology. Following paper has documented most recent progress in this field: Mining genome sequencing data to identify the genomic features linked to breast cancer histopathology. Journal of Pathology Informatics. 2014; 5: 3 (http://www.jpathinformatics.org/temp/JPatholInform513-3998243_110622.pdf). For the 2nd project, we are developing a lectin based, near infrared (NIR) optical imaging method that is capable of identifying limited amount of cancer on a larger surgical margin in a shorter period of time.

Selected Publications 
Publication PUBMEDID
Zheng Ping, Gene Siegal, Jonas Almeida, Stuart Schnitt and Dejun Shen. Mining genome sequencing data to identify the genomic features linked to breast cancer histopathology. J Pathology Informatics. 2014; 5: 3
 
24672738 
Rice MS, Tamimi RM, Connolly JL, Collins LC, Shen D, Pollak MN, Rosner B, Hankinson SE, Tworoger SS. Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II. Breast Cancer Res. 2012; 14(2): R44. [Epub ahead of print]   22414675 
Lee HC, Zhou C, Cohen DW, Mondelblatt AE, Wang Y, Aguirre AD, Shen D, Sheikine Y, Fujimoto JG, Connolly JL. Integrated optical coherence tomography and optical coherence microscopy imaging of ex vivo human renal tissues.
J Urol. 2012;187(2): 691-9.  
22177199 
He J, Whelan SA, Lu M, Shen D, Chung DU, Saxton RE, Faull KF, Whitelegge JP, Chang HR. Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic response. Int J Proteomics. 2011;2011:896476.  22110952 
Yang C, Hayashida T, Forster N, Li C, Shen D, Maheswaran S, Chen L, Anderson KS, Ellisen LW, Sgroi D and Schmidt EV. The integrin alpha v-beta 3,5 ligand MFG-E8 is a p63/p73 target gene in triple negative breast cancers but exhibits suppressive functions in ER+ and erbB2+ breast cancers. Cancer Research. 2011; 71(3): 937-45.   21127199 
Yoon NK, Maresh EL, Shen D, Elshimali Y, Apple S, Horvath S, Mah V, Bose S, Chia D, Chang HR, and Goodglick L. Higher Levels of GATA3 Predict Better Survival in Women with Breast Cancer. Human Pathology, 2010 Dec; 41(12): 1794-801.  21078439  
He J, Shen D, Chung DU, Saxton RE, Whitelegge JP, Faull KF, Chang HR. Tumor proteomic profiling predicts the susceptibility of breast cancer to chemotherapy. Int J Oncol. 2009; 35(4): 683-92.   19724903 
Wu Y, Shen D, Chen Z, Clayton S, Vadgama JV. Taxol induced apoptosis regulates amino acid transport in breast cancer cells. Apoptosis. 2007; 12(3): 593-612.  17195090 
He J, Gornbein J, Shen D, Lu M, Rovai LE, Shau H, Katz J, Whitelegge JP, Faull KF, Chang HR. Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometry. Int J Oncol. 2007; 30(1): 145-54.  17143523 
Shen D, Nooraie F, Elshimali Y, Lonsberry V, He J, Bose S, Chia D, Seligson D, Chang HR, Goodglick L. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol. 2006; 37(12): 1583-91.  16949910 
Vadgama JV, Scuric Z, Chakrabarti R, Marzo E, Shen D, Wu Y. Insulin-like growth factor I differentially regulates the expression of HIRF1/hCAF1 and BTG1 genes in human MCF-7 breast cancer cells. Int J Mol Med. 2006; 18(1): 129-39.  16786164 
Shen D, He J and Chang HR. In silico identification of breast cancer genes by combined multiple high throughput analyses. Int J of Mol Med, 2005; 15(2): 205-212  15647832 
Shen D, Chang HR, Chen Z, He J, Lonsberry V, Elshimali Y, Chia D, Seligson D, Goodglick D, Nelson S, and Gornbein J. Loss of annexin A1 expression in human breast cancer detected by multiple throughput analyses. Biochemical and Biophysical Research Communications, 2005; 326(1): 218-227  15567174 
He J, Shen D, O'Donnell MA, Chang HR. Induction of MUC1-specific cellular immunity by a recombinant BCG expressing human MUC1 and secreting IL2. Int J Oncol. 2002; 20(6): 1305-11.  12012014 

Keywords
Breast pathology, biomarker, bioinformatics